🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Renal Cell Carcinoma Stage I

Autologous Dendritic Cell Vaccine in Kidney Cancer NCT05127824Phase 21 site📍 Pittsburgh Jodi Maranchie · Tests: Autologous alpha-DC1/TBVA vaccine, Cabozantinib Sacituzumab Govitecan Plus EV in Metastatic UC NCT04724018Phase 1, Phase 21 site📍 Boston Dana-Farber Cancer Institute · Tests: Sacituzumab Govitecan (SG), Enfortumab vedotin-ejfv (EV), Pembrolizumab GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours NCT07297667Phase 14 sites📍 Calgary📍 Ottawa📍 Toronto Canadian Cancer Trials Group · Tests: Fludarabine, Cyclophosphamide, GCAR1 IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma NCT06321250Phase 11 site📍 Beijing Jemincare · Tests: JMKX003948 Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) NCT05665361Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Sasanlimab, Palbocicilib Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Becotatug Vedotin Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma NCT07072234Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Lymphodepleting chemotherapy, Dexamethasone, Fludarabine, Cyclophosphamate, TGFBR-2 KO CD70 CAR NK Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site📍 Adelaide SAPU NANO (US) LLC · Tests: Sapu003, Exemestane 25 MG To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer NCT07647744Phase 11 site📍 Shanghai Hrain Biotechnology Co., Ltd. · Tests: Anti-Human CD70 T-Cell Injection Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial NCT06866262Phase 1, Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Inulin, Ipilimumab [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers NCT06479811Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: [212Pb]VMT-alpha-NET, [203Pb]VMT-alpha-NET, 68Ga-DOTATATE A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. NCT06883539Phase 12 sites📍 Taichung📍 Tainan LaunXP Biomedical Co., Ltd. · Tests: LXP1788 is administered intravenously via Port-A A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial NCT06040762NA1 site📍 Seattle University of Washington · Tests: Best Practice, Exercise Intervention, App-Based Intervention, App-Based Intervention, Interview A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors NCT05518253Phase 11 site📍 Hangzhou Weijia Fang, MD · Tests: CD70 CAR-T cells, CD70 CAR-T cells Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer NCT06380816Phase 1, Phase 24 sites📍 London📍 Manchester📍 Newcastle upon Tyne Cancer Research UK · Tests: UCB4594 IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma NCT06819293Phase 11 site📍 Wuhan Grit Biotechnology · Tests: IB-T101 injection A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors NCT06553339Phase 11 site📍 Beijing Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: Oral HS-10516 A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies NCT06839105Phase 113 sites📍 Fuzhou📍 Guangzhou📍 Harbin Shanghai Junshi Bioscience Co., Ltd. · Tests: Taxol, Cisplatin or Carboplatin, Pemetrexed, Oxaliplatin, Capecitabine An Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With Everolimus NCT06730672Phase 22 sites📍 Guangzhou📍 Zhengzhou Sun Yat-sen University · Tests: Vorolanib combined with Everolimus Formation Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC NCT06222593Phase 1, Phase 21 site📍 Buffalo State University of New York at Buffalo · Tests: Bicalutamide in combination with Sunitinib Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial NCT06432036Phase 1, Phase 22 sites📍 Los Angeles📍 Aurora Jonsson Comprehensive Cancer Center · Tests: Angiogram, Biospecimen Collection, Computed Tomography, Radioembolization, Single Photon Emission Computed Tomography First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours NCT05759923Phase 13 sites📍 Bydgoszcz📍 Otwock📍 Warsaw Molecure S.A. · Tests: OATD-02 Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma NCT05287945Phase 1, Phase 210 sites📍 Orange📍 Palo Alto📍 San Francisco Oncorena AB · Tests: Orellanine Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors NCT06792552Phase 117 sites📍 Orlando📍 Atlanta📍 New Orleans NextCure, Inc. · Tests: SIM0505 for injection, SIM0505 for injection GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors NCT06265025Phase 1, Phase 24 sites📍 Goyang-si📍 Seoul📍 Seoul GeneMedicine Co., Ltd. · Tests: GM103 (Part A), GM103 (Part B), GM103 and Pembrolizumab (Part C) Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection NCT05334069n/a747 sites📍 Anchorage📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Questionnaire Administration, Biospecimen Collection A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites📍 Grand Rapids📍 St Louis📍 Pittsburgh AstraZeneca · Tests: AZD6750, rilvegostomig
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy